Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

US Pharmaceuticals Ishares ETF (IHE)

US Pharmaceuticals Ishares ETF (IHE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 335,156,000
  • Market Capitalization, $K 335,156
  • Shares Outstanding, K 2,300
  • 60-Month Beta 1.04
  • Price/Earnings ttm 27.41
  • Annual Dividend & Yield 2.07 (1.42%)
  • Most Recent Dividend 0.630 on 09/24/19
  • Management Fee 0.42%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
140.57 +4.65%
on 10/23/19
147.10 unch
on 11/20/19
+5.55 (+3.92%)
since 10/18/19
3-Month
136.66 +7.64%
on 10/02/19
147.10 unch
on 11/20/19
+6.80 (+4.85%)
since 08/20/19
52-Week
131.91 +11.52%
on 12/24/18
161.06 -8.67%
on 12/04/18
-4.96 (-3.26%)
since 11/20/18

Most Recent Stories

More News
Pharma ETFs Set to Benefit Post Strong Q3 Earnings

Robust results led to solid trading in pharma ETFs in a month.

XPH : 39.62 (+1.51%)
PJP : 61.85 (+0.21%)
PPH : 61.04 (-0.80%)
IHE : 147.55 (+0.69%)
FTXH : 22.07 (+0.36%)
JNJ Beats, Ups View: Healthcare ETFs to Buy

Johnson & Johnson continued its long streak of earnings beat and outpaced revenue estimates. It also raised its guidance for the full year.

JNJ : 135.07 (+0.19%)
XLV : 97.74 (-0.05%)
IYH : 205.50 (-0.04%)
IHE : 147.55 (+0.69%)
VHT : 182.67 (+0.09%)
IEIH : 26.80 (+0.34%)
Pharma Q2 Earnings Growth Highest: Time to Buy ETFs?

Despite robust results, pharma ETFs have been trending downward in a month.

PJP : 61.85 (+0.21%)
XPH : 39.62 (+1.51%)
PPH : 61.04 (-0.80%)
IHE : 147.55 (+0.69%)
FTXH : 22.07 (+0.36%)
Healthcare ETFs in Focus on JNJ's Q2 Earnings Beat

Johnson & Johnson beat the second-quarter earnings and revenue estimates but warned on competition from generics and biosimilars that could impact its third-quarter results.

JNJ : 135.07 (+0.19%)
IHE : 147.55 (+0.69%)
XLV : 97.74 (-0.05%)
IYH : 205.50 (-0.04%)
VHT : 182.67 (+0.09%)
IEIH : 26.80 (+0.34%)
AbbVie to Buy Allergan: Prescribed ETFs

AbbVie has agreed to buy Botox-maker Allergan for $63 billion in a cash-and-stock deal. The news has put the spotlight on a number of healthcare ETFs.

BMY : 55.87 (-1.08%)
AGN : 184.44 (-0.42%)
ABBV : 87.53 (-1.67%)
BBH : 136.33 (+0.60%)
PPH : 61.04 (-0.80%)
XPH : 39.62 (+1.51%)
IHE : 147.55 (+0.69%)
PJP : 61.85 (+0.21%)
CELG : 108.06 (-0.06%)
Pharma ETFs Down Despite Solid Q1 Results

Despite such robust results, pharma ETFs have been trending downward in a month.

XPH : 39.62 (+1.51%)
PJP : 61.85 (+0.21%)
IHE : 147.55 (+0.69%)
PPH : 61.04 (-0.80%)
FTXH : 22.07 (+0.36%)
Pharma ETFs Down Despite Solid Q1 Results

Despite such robust results, pharma ETFs have been trending downward in a month.

XPH : 39.62 (+1.51%)
PJP : 61.85 (+0.21%)
IHE : 147.55 (+0.69%)
PPH : 61.04 (-0.80%)
FTXH : 22.07 (+0.36%)
JNJ Beats, Ups Sales Growth View: Healthcare ETFs in Focus

Johnson & Johnson continued its long streak of earnings beat and also outpaced revenue estimates. Though it raised the guidance for full-year sales growth, it tightened the earnings per share forecast....

XLV : 97.74 (-0.05%)
VHT : 182.67 (+0.09%)
IHE : 147.55 (+0.69%)
IYH : 205.50 (-0.04%)
IEIH : 26.80 (+0.34%)
JNJ Beats, Ups Sales Growth View: Healthcare ETFs in Focus

Johnson & Johnson continued its long streak of earnings beat and also outpaced revenue estimates. Though it raised the guidance for full-year sales growth, it tightened the earnings per share forecast....

XLV : 97.74 (-0.05%)
VHT : 182.67 (+0.09%)
IHE : 147.55 (+0.69%)
IYH : 205.50 (-0.04%)
IEIH : 26.80 (+0.34%)
Why These Pharma ETFs Rallied on Thursday

A few pharma ETFs hit a one-month high on Feb 28. Why?

XPH : 39.62 (+1.51%)
IHE : 147.55 (+0.69%)
PJP : 61.85 (+0.21%)
TGTX : 7.91 (-0.25%)
HZNP : 31.26 (+2.49%)
RKDA : 4.58 (+0.88%)
FTXH : 22.07 (+0.36%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade IHE with:

Fund Summary

The iShares U.S. Pharmaceuticals ETF seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector. The Fund seeks investment results that correspond to the price and yield of the Dow Jones U.S. Select Pharmaceuticals Index.

See More

Key Turning Points

2nd Resistance Point 147.15
1st Resistance Point 146.84
Last Price 147.55
1st Support Level 146.13
2nd Support Level 145.73

See More

52-Week High 161.06
Fibonacci 61.8% 149.92
Last Price 147.55
Fibonacci 50% 146.49
Fibonacci 38.2% 143.05
52-Week Low 131.91

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar